[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"temperature-change-body\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:temperature-change-body":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,51,79,117,156],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":50},"100606332","the-impact-of-wearing-the-hijab-on-whole-body-heat-loss-during-exercise-heat-stress-100606332",false,"NCT07174180","The Impact of Wearing the Hijab on Whole-body Heat Loss During Exercise-heat Stress","The Effect of Wearing the Hijab on Dry and Evaporative Heat Exchange During Moderate-intensity Exercise Performed in Hot-dry Environments","Inclusion Criteria:\n\n* healthy young female (18-35 years)\n* non smoking\n* English or French speaking\n* ability to provide informed consent\n\nExclusion Criteria:\n\n* claustrophobia\n* engaged in endurance training\n* acute or chronic illness\n* sedentary (not engaged in any form of physical activity)\n* physical restriction limiting physical activity",true,"FEMALE","18 Years","35 Years",{"count":21,"type":22},12,"ESTIMATED","INTERVENTIONAL",[25],"NA","The hijab (headscarf and cloak) is a Muslim dress, which covers the head, neck and chest, and conceals the female hair, leaving the face uncovered. It is worn by Muslim women worldwide including young Muslim women engaging in sports and exercise. As with any clothing worn on the body, the hijab can impact heat dissipation during exercise, potentially leading to increased body temperature and discomfort, especially in warmer environments. However, the extent to which the hijab may restrict heat loss remains unclear. This study aims to assess dry and evaporative heat exchange in young women performing moderate-intensity intermittent exercise in dry heat conditions (40°C, 15% relative humidity).",[28,29],"Heat Stress","Temperature Change, Body",[31,32,33,34,35,36,37],"Core temperature","Exercise","Females","Garment","Heat strain","Thermoregulation","Hot weather","RECRUITING","2026-06-12",{"date":41,"type":42},"2026-06-16","ACTUAL",{"date":44,"type":42},"2025-06-13",{"date":46,"type":22},"2026-12-31",{"name":48,"class":49},"University of Ottawa","OTHER",1,{"id":52,"slug":53,"hasResults":11,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":4,"eligibilityCriteria":57,"healthyVolunteers":11,"sex":58,"minAge":18,"maxAge":4,"enrollmentInfo":59,"targetDuration":4,"studyType":60,"phases":4,"briefSummary":61,"conditions":62,"keywords":63,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":50},"100623542","feasibility-of-wearable-based-continuous-temperature-monitoring-100623542","NCT07397988","Feasibility of Wearable-Based Continuous Temperature Monitoring","Feasibility Study for Logistics and Data Stability of Continuous Temperature Monitoring Using a Wearable Device With a Continuous Core Temperature Reference Method","Inclusion Criteria:\n\n* Written informed consent obtained prior to any project-specific procedures.\n* Age 18 years or older at enrolment.\n* Able and willing to comply with project procedures, including capsule ingestion, continuous wearable use for around 48 hours, and adherence to study instructions.\n* Able to swallow the ingestible temperature capsule without difficulty.\n* No contraindication to ingestible thermometry as assessed by the investigator.\n\nExclusion Criteria:\n\nGeneral:\n\n* Body weight \\\u003C 36 kg.\n* Women who are pregnant.\n* Participation in another clinical investigation involving an investigational medicinal product or medical device within the 30 days preceding enrolment or previous enrolment in the current project.\n* Enrolment of the Principal Investigator, project staff, their family members, employees, or other dependent persons.\n* Inability to provide valid informed consent or significant language barrier preventing adequate understanding of procedures.\n\nImplants \\& MRI:\n\n* Presence of any active Implantable Medical Device (AIMD), including Pacemakers, Implantable Cardioverter Defibrillators (ICDs), Deep Brain Stimulation (DBS) devices, or Left Ventricular Assist Devices (LVADs).\n* Requirement for MRI scanning during the seven days following the capsule intake.\n\nCognitive\u002FPhysical Status:\n\n* Unconscious patients (prior to ingestion).\n* Patients with special needs or disabilities preventing safe autonomous swallowing.\n\nGastrointestinal:\n\n* Known history of dysphagia or gag reflex troubles.\n* Previous gastrointestinal surgery resulting in bowel stenosis.\n* Current or planned surgical procedures on the GI tract (esophagus, stomach, intestines).\n* Zenker's diverticulum or felinization of the esophagus.\n* Risk or history of intestinal obstruction, strictures, or diverticula.\n* Hypomotility disorders (e.g., ileus).\n* Inflammatory Bowel Diseases including Crohn's disease or Ulcerative Colitis.\n\nDermatological Exclusions (Rheo Vital+ Performance)\n\n* Dermatological conditions, wounds, tattoos, oedema, inflammation, active venous access, or other impairments at the medial upper arm or axillary region that could interfere with correct placement or functioning of the wearable device.\n* Excessive hair or concurrent devices that hinder correct sensor placement.\n* Known allergy to plastics or latex.\n\nTemperature Management:\n\n* Active external heating or cooling (e.g., cooling blankets).\n* Note: Use of pharmacological antipyretics (oral\u002FIV) is permitted.\n\nFurther Medical Conditions:\n\n* Currently existing acute back pain.\n* Symptomatic herniated disc.","ALL",{"count":21,"type":22},"OBSERVATIONAL","The aim of this study is to evaluate the feasibility of collecting synchronised continuous temperature data using wearable devices and a continuous core temperature reference under real-world conditions. The study focuses on workflow execution, data continuity, secure retrieval, and time-alignment without diagnostic or therapeutic intent.",[29],[64,65,66,67,68],"Continuous temperature monitoring","Wearable devices","Feasibility study","Ingestible temperature capsule","Real-world monitoring","NOT_YET_RECRUITING","2026-02-02",{"date":72,"type":42},"2026-02-09",{"date":74,"type":22},"2026-03",{"date":76,"type":22},"2027-03",{"name":78,"class":49},"University Hospital, Basel, Switzerland",{"id":80,"slug":81,"hasResults":11,"nctId":82,"briefTitle":83,"officialTitle":84,"acronym":85,"eligibilityCriteria":86,"healthyVolunteers":11,"sex":58,"minAge":18,"maxAge":87,"enrollmentInfo":88,"targetDuration":4,"studyType":23,"phases":90,"briefSummary":91,"conditions":92,"keywords":94,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":116},"100570183","performance-study-of-the-thermodiag-solution-for-body-temperature-measurement-100570183","NCT06703931","Performance Study of the Thermodiag Solution for Body Temperature Measurement","Evaluation of PERThermodiag® Medical Device for CT Temperature Measurement and Anomaly Detection Compared to Reference Methods in Critical Care Hospitalized Patients: a Comparative, Multi-center Interventional Study","ThermodiagPERF","Inclusion Criteria:\n\n* Patients aged 18 to 80 years;\n* Female or male patients;\n* Patients hospitalised in a critical care unit as defined by the Public Health Code of the Republic of France, Article R6123-33: 'The critical care activity consists of the care of patients who present or are likely to present one or more acute failures directly threatening the vital or functional prognosis and which may require recourse to one or more methods of substitution'.\n* Patients affiliated to the social security system or beneficiaries of such a system, where applicable, in accordance with local regulations;\n* Voluntary patients - or trusted person\u002Ffamily member\u002Frelative who have given oral and written consent after being informed by the investigator of the research.\n\nExclusion Criteria:\n\n* Patients with a corpulence or physical characteristics responsible for a 'tourniquet' effect: arm circumference greater than 47 centimetres;\n* Patients with burns on the arm (location for Thermodiag® measurement);\n* Patients with particularly sensitive or affected skin in the biceps or armpit (left and right);\n* Patients undergoing an MRI examination;\n* Patients undergoing extracorporeal circulation;\n* Patients with a history of allergy to silicone;\n* Patients with active implantable medical devices such as pacemakers, defibrillators, etc. ;\n* Patients undergoing dialysis;\n* Patients with a tattoo in the area where the investigational device will be worn (arm);\n* Patients currently excluded from another protocol or taking part in another interventional research study;\n* Pregnant or breast-feeding women.","80 Years",{"count":89,"type":22},60,[25],"The goal of this prospective, comparative, multi-centre interventional clinical investigation, is to evaluate the performance of the Thermodiag® medical device, compared with reference methods, for continuous measurement of core temperature in critical care patients. The main question it aims to answer is to develop non-invasive alternatives to the current methods of measuring core body, to reduce health risks, and overcome various other limitations (as infection, bleeding, thrombosis and local reactions).",[29,93],"Emergency Department Visit",[95,96,97,98,99,100,101,102,103,104,105],"Temperature","Body temperature","Monitoring temperature","multisensors","Actimetry","Actigraphy","Heart rate","Continuous measurement","Contextualized measure","Dedicated machine learning model","Machine Learning","2024-11-21",{"date":108,"type":42},"2024-11-25",{"date":110,"type":22},"2024-11-26",{"date":112,"type":22},"2025-03-30",{"name":114,"class":115},"F2D Medical","INDUSTRY",4,{"id":118,"slug":119,"hasResults":11,"nctId":120,"briefTitle":121,"officialTitle":122,"acronym":123,"eligibilityCriteria":124,"healthyVolunteers":16,"sex":58,"minAge":18,"maxAge":125,"enrollmentInfo":126,"targetDuration":128,"studyType":60,"phases":4,"briefSummary":129,"conditions":130,"keywords":4,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":147,"lastUpdatePostDateStruct":148,"startDateStruct":150,"completionDateStruct":152,"leadSponsor":154,"locationsCount":50},"100498046","safe-brain-initiative-operationalizing-precision-anaesthesia-100498046","NCT05765162","Safe Brain Initiative, Operationalizing Precision Anaesthesia","Safe Brain Initiative - Dedicated to Advancing Anaesthesia and Perioperative Personalised Care Towards Precision Anaesthesia Care. A Continuous Quality Improvement Initiative.","SBI","Inclusion Criteria:\n\n• All patients from age ≥18\n\nExclusion Criteria:\n\n• All patients from age \\\u003C18","100 Years",{"count":127,"type":22},15000,"5 Years","Perioperatively, patients experience an unnecessarily high level of side effects associated with their treatment. These side effects include nausea, severe pain, anxiety, and stress. Moreover, many patients develop postoperative delirium (POD) and neurocognitive dysfunctions, often resulting in long-term cognitive impairment, decreased quality of life, and increased mortality. However, physicians, nurses and their institutions do not receive structured feedback regarding these aspects of each patient's well-being. They may therefore be unable to engage in the essential cause-and-effect learning necessary to evaluate and consecutively reduce such side effects.\n\nEffective guidelines conform prevention is the proven key to shielding our patients from adverse Outcomes. The Safe Brain Initiative's high-quality routine data-for-action is a sword and accelerator for moving towards patient-centred, precision care. Thus, establishing a foundation for value-based and patient-centred healthcare development.\n\nHowever, a turnkey real-world solution is challenging to develop and implement and requires substantial resources. As a result, such solutions are usually beyond the scope of a single institution. The SBI platform provides high-quality, real-world data to bridge this gap. It allows monitoring and in-depth analysis of cause and effect in the day-to-day routine of individuals, departments, and institutions.\n\nThe SBI's approach is continuously improved and updated. An organization called the SBI Global Society oversees the quality and precision of science through experts in the field. At SBI Hospitals and Flagship centres, Masterclasses are conducted and can be attended alongside clinical immersions.\n\nSBI Solutions manages, develops, and provides technical and service support for the Safe Brain Initiative. Its service guarantees the professional and GDPR conform management of data handling and storage as well as the user-friendly functionality of the SBI-Dashboard solutions.",[131,132,133,134,135,136,137,138,139,140,141,142,143,29,144,145,146],"Neurocognitive Disorders","Post Operative Delirium","Pain","Nausea","Vomiting","Wellbeing","Shivering","Anxiety","Stress","Agitation,Psychomotor","Sedation Complication","Thirst","Satisfaction, Patient","Fasting","Sore-throat","Hearing and Vision Loss","2024-06-05",{"date":149,"type":42},"2024-06-07",{"date":151,"type":42},"2021-12-01",{"date":153,"type":22},"2026-01-01",{"name":155,"class":49},"University of Southern Denmark",{"id":157,"slug":158,"hasResults":11,"nctId":159,"briefTitle":160,"officialTitle":161,"acronym":162,"eligibilityCriteria":163,"healthyVolunteers":11,"sex":58,"minAge":18,"maxAge":4,"enrollmentInfo":164,"targetDuration":4,"studyType":60,"phases":4,"briefSummary":166,"conditions":167,"keywords":170,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":172,"lastUpdatePostDateStruct":173,"startDateStruct":175,"completionDateStruct":177,"leadSponsor":179,"locationsCount":50},"100437471","core-temperature-in-patients-with-ohca-100437471","NCT04976712","Core Temperature in Patients With OHCA","Core Temperature in Patients With Out of Hospital Cardiac Arrest in South Tyrol - a Prospective Observational Study","CT-OCHA","Inclusion Criteria:\n\n* Out of hospital cardiac arrest\n* Patients transferred to hospital\n* \\> 18 years\n\nExclusion Criteria:\n\n* Obvious signs of death\n* Obvious lethal injury\u002Finjuries incompatible with life\n* Confirmation of death on scene\n* \\\u003C 18 years",{"count":165,"type":22},256,"A prospective observational study aiming to monitor core temperature via an esophageal probe in out of hospital cardiac arrest during transport and until arrival in hospital. Insertion of an esophageal temperature probe will be done on scene during ongoing resuscitation manoeuvres based on European Resuscitation Council Guidelines 2015 (or newer). Environmental temperature influence and hypothermia prevention interventions will be monitored.",[168,169,29],"Out-Of-Hospital Cardiac Arrest","Accidental Hypothermia",[168,169,171],"Core Temperature","2022-12-16",{"date":174,"type":42},"2022-12-20",{"date":176,"type":42},"2021-07-01",{"date":178,"type":22},"2026-09-30",{"name":180,"class":49},"Azienda Sanitaria dell'Alto Adige"]